CClinicalTrials.gg
CompletedNCT05642065Updated May 1, 2023

Hip Activation and FSDT

An interventional study of Hip muscle activation home exercise program in Movement, Abnormal and Lower Extremity Problem, sponsored by Louisiana State University Health Sciences Center Shreveport. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-05-01.

Sponsored by Louisiana State University Health Sciences Center Shreveport · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to determine if activation training of the hip musculature affects muscle activation and frontal plane mechanics in healthy individuals.

Specific Aim 1: Determine whether performance on the forward step-down test (FSDT) changes after an eight-week home exercise program (HEP) focused on hip musculature activation in healthy individuals.

Specific Aim 2: Determine whether surface electromyography (sEMG) hip musculature changes following an eight-week HEP focused on hip musculature activation in healthy individuals.

Specific Aim 3: Determine whether a dose-response relationship exists between compliance on the HEP and changes in FSDT scores in healthy individuals.

Specific Aim 4: Determine whether a dose-response relationship exists between compliance on the HEP and sEMG changes in hip musculature activation in healthy individuals.

02

Conditions studied

  • Movement, Abnormal
  • Lower Extremity Problem

Browse trials for

03

In context

Dyskinesias

270 studies on the registry are indexed under Dyskinesias; 41 are open to participants now.

This study's enrollment of 35 is below the median of 44 across 192 interventional studies indexed under Dyskinesias.

Browse Dyskinesias studies →

Lead sponsor

Louisiana State University Health Sciences Center Shreveport is the lead sponsor of 43 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Participants must be current first or second year Doctor of Physical Therapy students in the School of Allied Health Professions at LSU Health Shreveport.

Exclusion criteria

Exclusion Criteria:

  • Current knee pain or pathology in the dominant leg, and women with known pregnancy.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
35 participants (actual)

Study arms

  • Experimental
    Arm 1

    Participants will undergo lower extremity movement assessment on the Forward Step Down Test before and after a home exercise program (HEP) consisting of five hip activation exercises. These exercises will be performed 2x/week for 8 weeks. Surface EMG of the gluteus maximus and medius, in addition to tracking of participant compliance on the HEP program will also be assessed pre- and post-intervention.

    Other: Hip muscle activation home exercise program

Interventions

  • OtherHip muscle activation home exercise program

    Participants will perform a home exercise program consisting of five hip muscle activation exercises with the use of a resistance band. The program will be eight weeks in duration, and participants will perform the exercises twice weekly.

06

What researchers measure

Primary outcomes

  1. Scores on the Forward Step Down Test

    Participants will perform the Forward Step Down Test pre- and post-intervention, while being score by two investigators simultaneously.

    Time frame: Pre- and Post- Intervention Program (8 weeks)

Secondary outcomes

  1. Surface electromyography (sEMG) - Gluteus Maximus

    sEMG data for the gluteus maximus, including both mean EMG activation and peak EMG activation will be recorded during performance of the Forward Step Down Test.

    Time frame: Pre- and Post- Intervention Program (8 weeks)

  2. Surface electromyography (sEMG) - Gluteus Medius

    sEMG data for the gluteus medius, including both mean EMG activation and peak EMG activation will be recorded during performance of the Forward Step Down Test.

    Time frame: Pre- and Post- Intervention Program (8 weeks)

  3. Home Exercise Program (HEP) Compliance

    Participants will complete a log of the number of HEP sessions they complete during the 8-week intervention program. The sum of sessions completed will be used as a measure of compliance.

    Time frame: Pre- and Post- Intervention Program (8 weeks)

07

Study locations

1 site
  • Louisiana State University Health Sciences Center - Shreveport
    Shreveport, Louisiana 71130, United States
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Nov 18, 2022
  • Informed consent form · Nov 18, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 1, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05642065
Lead sponsor
Louisiana State University Health Sciences Center Shreveport
Responsible party
Daniel W. Flowers (Assistant Professor of Physical Therapy, Louisiana State University Health Sciences Center Shreveport) — Principal investigator
First posted
Dec 8, 2022
Start date
Jan 26, 2023
Primary completion
Apr 28, 2023
Completion
Apr 28, 2023
Last update
May 1, 2023

Study contacts

Daniel W. Flowers, DPT, PhD
principal investigator · Louisiana State University Health Sciences Center Shreveport

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion